A study on non-coding RNA (Ribonucleic Acid) from prostate cancer patients has identified a series of new prostate cancer markers which can be found in urine. Combining these RNA markers into a single ...

Indiana University is leading the way in the development of groundbreaking nanotechnology to revolutionize screening for prostate cancer, the second leading cause of cancer death among men in the ...

NucleoBio and PreCheck Health Services Announce Strategic Collaboration to Advance Non-Invasive Prostate Cancer Testing NucleoBio, Corp., a leading biotechnology innovator in precision oncology ...

A new mobile prostate cancer screening bus will begin visiting neighborhoods this month, offering free screenings to raise awareness and promote early detection. The initiative, supported by the ...

A remarkable scientific advancement could transform how prostate cancer is detected in men around the world. Researchers have developed a groundbreaking urine test that offers significant advantages ...

A know-how licensing agreement for a non-invasive electrochemical screening technology, based on research by Prof. A. L. Roy Vellaisamy, Chair Professor of Intelligent Systems in the School of Science ...

WASHINGTON (DC News Now) — September is Prostate Cancer Awareness Month, and according to the National Cancer Institute (NCI), approximately one in eight men will be diagnosed with prostate cancer in ...

* New urine biomarker test shows over 90% accuracy in detecting prostate cancer * Test works even when PSA levels appear normal * Biomarker levels drop after //surgery, confirming prostate origin ...

Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital and four other institutions have devised a novel method to test for prostate cancer using biomarkers ...

Jeffrey Tosoian, MD, assistant professor of Urology and director of Translational Cancer Research at Vanderbilt University Medical Center. The results are important because this could enable at-home ...

Prostate Screening EpiSwitch (PSE) blood test shows significant potential as an accurate and rapid cancer screening diagnostic High accuracy (94%), PPV (92%), and NPV (94%) reported in the high-impact ...